Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02667535
What this trial is testing

PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure

Who this might be right for
Anal Fissure
Biolab Sanus Farmaceutica
Not applicableUnknownNCT06170138
What this trial is testing

Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users

Who this might be right for
Nicotine Use Disorder
Amplicon AB 12
Post-approval studies (Phase 4)Study completedNCT00969852
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Sertraline After Low Dose Administration

Who this might be right for
Healthy
Seoul National University Hospital 10
Early research (Phase 1)Looking for participantsNCT07283796
What this trial is testing

Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
NHL
Haisco Pharmaceutical Group Co., Ltd. 110
Early research (Phase 1)Study completedNCT01429688
What this trial is testing

Pharmacokinetic / Pharmacodynamic (PK/PD) Study of Multiple Doses of DP-R202 in Healthy Volunteers

Who this might be right for
Healthy
Alvogen Korea 36
Early research (Phase 1)Study completedNCT05756920
What this trial is testing

This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants

Who this might be right for
Healthy
ABL Bio, Inc. 91
Testing effectiveness (Phase 2)Ended earlyNCT05574010
What this trial is testing

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

Who this might be right for
Celiac Disease
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA 128
Early research (Phase 1)Ended earlyNCT01808482
What this trial is testing

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT05428696
What this trial is testing

Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 90
Early research (Phase 1)Looking for participantsNCT06809114
What this trial is testing

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Axcynsis Therapeutics Pte Ltd 83
Not applicableStudy completedNCT01602614
What this trial is testing

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Who this might be right for
Cytomegalovirus Infections
University of Alabama at Birmingham 18
Large-scale testing (Phase 3)Study completedNCT01625390
What this trial is testing

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

Who this might be right for
Hemophilia A, Hemophilia B
Bayer 10
Early research (Phase 1)Study completedNCT05803850
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of HNC1058

Who this might be right for
IPF
Guangzhou Henovcom Bioscience Co. Ltd. 32
Large-scale testing (Phase 3)Study completedNCT07560150
What this trial is testing

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

Who this might be right for
PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc. 62
Early research (Phase 1)UnknownNCT03645278
What this trial is testing

The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Who this might be right for
Hypertension
Jiangsu HengRui Medicine Co., Ltd. 50
Not applicableLooking for participantsNCT06651047
What this trial is testing

PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections

Who this might be right for
Gram Negative InfectionAntimicrobial Resistance (AMR)
University of Bologna 120
Testing effectiveness (Phase 2)Study completedNCT06922448
What this trial is testing

Study of BLU-808 in Allergic Rhinoconjunctivitis

Who this might be right for
Allergic Rhinoconjunctivitis
Blueprint Medicines Corporation 21
Early research (Phase 1)UnknownNCT01664221
What this trial is testing

PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.

Who this might be right for
Healthy
Azidus Brasil 80
Early research (Phase 1)Study completedNCT02765633
What this trial is testing

Cangrelor Neonatal PK/PD and Safety Study

Who this might be right for
Partial Obstruction of Systemic to Pulmonary Artery ShuntComplete Obstruction of Systemic to Pulmonary Artery Shunt
Chiesi Farmaceutici S.p.A. 22
Early research (Phase 1)Looking for participantsNCT07235059
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Novartis Pharmaceuticals 112
Next Page